John Hartman

1.4k total citations
67 papers, 998 citations indexed

About

John Hartman is a scholar working on Oncology, Electrical and Electronic Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John Hartman has authored 67 papers receiving a total of 998 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Electrical and Electronic Engineering and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John Hartman's work include Spectroscopy and Laser Applications (10 papers), PARP inhibition in cancer therapy (8 papers) and Ovarian cancer diagnosis and treatment (8 papers). John Hartman is often cited by papers focused on Spectroscopy and Laser Applications (10 papers), PARP inhibition in cancer therapy (8 papers) and Ovarian cancer diagnosis and treatment (8 papers). John Hartman collaborates with scholars based in United States, Sweden and Finland. John Hartman's co-authors include Jacek Klinowski, Colin A. Fyfe, John Meurig Thomas, Subramaniam Ramdas, D.L. Lessor, Richard Gordon, James Floyd Kelly, Steven W. Sharpe, Claire Gmachl and Federico Capasso and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

John Hartman

60 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Hartman United States 15 288 191 168 129 119 67 998
Morihisa Saeki Japan 23 240 0.8× 57 0.3× 169 1.0× 119 0.9× 62 0.5× 72 1.3k
Steven G. Hansen United States 18 239 0.8× 333 1.7× 59 0.4× 326 2.5× 79 0.7× 51 1.4k
Gérard Durand France 19 87 0.3× 88 0.5× 73 0.4× 82 0.6× 191 1.6× 63 855
Kenji Shimizu Japan 20 93 0.3× 118 0.6× 46 0.3× 292 2.3× 60 0.5× 181 1.4k
C.J. Allan Sweden 12 101 0.4× 118 0.6× 98 0.6× 168 1.3× 62 0.5× 14 986
R. E. Shefer United States 17 77 0.3× 196 1.0× 45 0.3× 106 0.8× 147 1.2× 50 1.3k
Margarita Martı́n Spain 32 434 1.5× 136 0.7× 37 0.2× 192 1.5× 329 2.8× 141 3.2k
Finn Rasmussen Denmark 22 152 0.5× 297 1.6× 54 0.3× 291 2.3× 79 0.7× 117 2.1k
R. A. JACKSON United Kingdom 31 79 0.3× 104 0.5× 212 1.3× 192 1.5× 40 0.3× 90 3.1k
Hitoshi Miura Japan 20 73 0.3× 63 0.3× 197 1.2× 201 1.6× 26 0.2× 97 1.6k

Countries citing papers authored by John Hartman

Since Specialization
Citations

This map shows the geographic impact of John Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hartman more than expected).

Fields of papers citing papers by John Hartman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hartman. The network helps show where John Hartman may publish in the future.

Co-authorship network of co-authors of John Hartman

This figure shows the co-authorship network connecting the top 25 collaborators of John Hartman. A scholar is included among the top collaborators of John Hartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Hartman. John Hartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Thaker, Premal H., Sara Burns, Jonathan Lim, et al.. (2024). Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study. International Journal of Gynecological Cancer. 34(12). 1924–1931.
3.
Rimel, B.J., Sara Burns, Jonathan Lim, et al.. (2024). Real-World First-Line Maintenance Niraparib Monotherapy Use Following Chemotherapy Plus Bevacizumab: The SW1TCH Study. Oncology and Therapy. 12(3). 465–475.
4.
Sargsyan, Davit, Javier Cabrera, Christine M. Livingston, et al.. (2023). Automated Spot Counting in Microbiology. IEEE/ACM Transactions on Computational Biology and Bioinformatics. 20(6). 3703–3714. 1 indexed citations
5.
Sugarman, Ryan, Keith A. Betts, Xiaoyu Nie, John Hartman, & Hiep Nguyen. (2023). Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: Analysis of Number Needed To Treat and Number Needed To Harm. Clinical Therapeutics. 45(11). 1155–1158. 1 indexed citations
6.
7.
8.
Kudrik, Fred J., et al.. (2023). PARPi monotherapy as first-line maintenance following chemotherapy + bevacizumab in advanced ovarian cancer.. Journal of Clinical Oncology. 41(16_suppl). e17601–e17601. 1 indexed citations
9.
Stenehjem, David D., Solomon J. Lubinga, Keith A. Betts, et al.. (2021). Treatment Patterns in Patients with Metastatic Non-Small-Cell Lung Cancer in the Era of Immunotherapy. Future Oncology. 17(22). 2940–2949. 14 indexed citations
10.
Waterhouse, David, Jenny Lam, Keith A. Betts, et al.. (2021). Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer. Lung Cancer. 156. 41–49. 88 indexed citations
11.
Hatschek, Thomas, Anne Andersson, Judith Bjöhle, et al.. (2020). 97O PREDIX HER2 trial: Event-free survival and pathologic complete response in clinical subgroups and stromal TILs levels. Annals of Oncology. 31. S49–S49. 4 indexed citations
12.
Latifkar, Arash, Ling Lu, Xiaoyu Zhang, et al.. (2019). Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity. Developmental Cell. 49(3). 393–408.e7. 113 indexed citations
13.
Hartman, John & Brian J. Kirby. (2017). Decorrelation correction for nanoparticle tracking analysis of dilute polydisperse suspensions in bulk flow. Physical review. E. 95(3). 33305–33305. 5 indexed citations
14.
Sharpe, Steven W., James Floyd Kelly, Richard M. Williams, et al.. (1999). Rapid scan (Doppler-limited) absorption spectroscopy using mid-infrared quantum cascade lasers. Proceedings of SPIE - The International Society for Optical Engineering. 3758. 23–33. 1 indexed citations
15.
Williams, Richard M., James Floyd Kelly, Steven W. Sharpe, et al.. (1999). Spectral and modulation performance of quantum cascade lasers with application to remote sensing. Proceedings of SPIE - The International Society for Optical Engineering. 3758. 11–22. 1 indexed citations
16.
Phillips, George, et al.. (1992). Hypothyroidism in adults with sickle cell anemia. The American Journal of Medicine. 92(5). 567–570. 18 indexed citations
17.
Phillips, George, et al.. (1990). Regulation of Tissue Plasminogen Activator in Sickle Cell Anemia. American Journal of Hematology. 35(3). 167–170. 8 indexed citations
18.
Phillips, George, John Hartman, Thomas R. Kinney, Joseph E. Sokal, & Russel E. Kaufman. (1988). Chronic granulocytic leukemia in a patient with sickle cell anemia. The American Journal of Medicine. 85(4). 567–569. 7 indexed citations
19.
Phillips, George, et al.. (1988). Totally implantable intravenous catheters in the management of sickle cell anemia. American Journal of Hematology. 29(3). 134–138. 28 indexed citations
20.
Kotler, Morris N., et al.. (1985). Renal cell carcinoma and right atrial tumor diagnosed by echocardiography. American Heart Journal. 110(1). 183–186. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morihisa Saeki Breakdown of academic impact, for papers by Steven G. Hansen Breakdown of academic impact, for papers by Gérard Durand Breakdown of academic impact, for papers by Kenji Shimizu Breakdown of academic impact, for papers by C.J. Allan Breakdown of academic impact, for papers by R. E. Shefer Breakdown of academic impact, for papers by Margarita Martı́n Breakdown of academic impact, for papers by Finn Rasmussen Breakdown of academic impact, for papers by R. A. JACKSON Breakdown of academic impact, for papers by Hitoshi Miura
Rankless by CCL
2026